Physician profile
Jonathan Mcmath
NPI 1508880873
$1,293.00
in general payments reported to CMS, 2019-2025
13 companies · $377 in 2025
The $377 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2021: $121 · 2022: $46.71 · 2023: $117 · 2024: $340 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $382.28 | 2021-2025 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $286.98 | 2025 | Jornay Pm |
| Corium, LLC | $178.91 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $172.33 | 2019-2024 | |
| Neos Therapeutics, Lp | $75.77 | 2019 | |
| Shire North American Group INC | $43.89 | 2019 | |
| Pfizer INC. | $31.97 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $28.22 | 2019-2025 | Vaxneuvance, Vaxelis, Rotateq |
| Cranial Technologies, INC | $25.64 | 2019 | |
| Glaxosmithkline, LLC. | $19.00 | 2019 | |
| Sobi, INC | $18.06 | 2019 | |
| Rhodes Pharmaceuticals L.P. | $16.68 | 2019 | |
| Tris Pharma INC | $13.27 | 2024 | Onyda Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mcmath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.